Date: 2019-09-27Category: Not ApplicableState: Union GovernmentCountry: Europe
Decision (EU) 2019/1487 of the European Parliament of 26 March 2019 on the closure of the accounts of the European Medicines Agency for the financial year 2017
**Executive Summary:**
This is a decision by the European Parliament concerning the closure of the accounts of the European Medicines Agency for the financial year 2017. It references the Court of Auditors' report, relevant regulations, and internal rules of procedure. The decision approves the closure of the accounts and instructs the President to forward the decision to relevant parties and arrange for its publication.
**Key Points / Main Content:**
* **Approval:**
* The European Parliament approves the closure of the accounts of the European Medicines Agency for the financial year 2017.
* **Instructions:**
* The President of the European Parliament is instructed to forward the decision to:
* The Executive Director of the European Medicines Agency
* The Council
* The Commission
* The Court of Auditors
* The President is also instructed to arrange for the publication of the decision in the Official Journal of the European Union L series.
**Impact Analysis**
**European Medicines Agency (Executive Director):**
* *Impact:* Must take note of the approved closure of accounts for 2017 and receive the decision document.
* *Action Required:* No specific action required beyond noting the decision.
**Council:**
* *Impact:* Must receive the decision document.
* *Action Required:* No specific action required beyond noting the decision.
**Commission:**
* *Impact:* Must receive the decision document.
* *Action Required:* No specific action required beyond noting the decision.
**Court of Auditors:**
* *Impact:* Must receive the decision document.
* *Action Required:* No specific action required beyond noting the decision.
**President of the European Parliament:**
* *Impact:* Responsible for enacting the decision.
* *Action Required:* Forward the decision to the specified recipients and arrange for its publication in the Official Journal.
Key Entities Referenced
European Parliament: The legislative branch of the European Union.
European Medicines Agency: A decentralised agency of the European Union responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
Court of Auditors: The European Court of Auditors (ECA) is the EU institution tasked with auditing EU finances.
Treaty on the Functioning of the European Union: One of the primary treaties of the European Union, defining its scope and operation.
Council of the European Union: A component of the EU legislative branch representing the governments of the member states.
Regulation (EU, Euratom) No 966/2012: Regulation of the European Parliament and of the Council on the financial rules applicable to the general budget of the Union.
Regulation (EU, Euratom) 2018/1046: Regulation of the European Parliament and of the Council on the financial rules applicable to the general budget of the Union.
Regulation (EC) No 726/2004: Regulation of the European Parliament and of the Council laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency.
L 249/238 EN Official Journal of the European Union 27.9.2019
DECISION (EU) 2019/1487 OF THE EUROPEAN PARLIAMENT
of 26 March 2019
on the closure of the accounts of the European Medicines Agency for the financial year 2017
THE EUROPEAN PARLIAMENT,
— having regard to the final annual accounts of the European Medicines Agency for the financial year 2017,
— having regard to the Court of Auditors' report on the annual accounts of the European Medicines Agency for the
financial year 2017, together with the Agency's reply (1),
— having regard to the statement of assurance (2) as to the reliability of the accounts and the legality and regularity of
the underlying transactions provided by the Court of Auditors for the financial year 2017, pursuant to Article 287
of the Treaty on the Functioning of the European Union,
— having regard to the Council's recommendation of 12 February 2019 on discharge to be given to the Agency in
respect of the implementation of the budget for the financial year 2017 (05825/2019 – C8-0075/2019),
— having regard to Article 319 of the Treaty on the Functioning of the European Union,
— having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of
25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council
Regulation (EC, Euratom) No 1605/2002 (3), and in particular Article 208 thereof,
— having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July
2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU)
No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU)
No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation
(EU, Euratom) No 966/2012 (4), and in particular Article 70 thereof,
— having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004
laying down Community procedures for the authorisation and supervision of medicinal products for human and
veterinary use and establishing a European Medicines Agency (5), and in particular Article 68 thereof,
— having regard to Commission Delegated Regulation (EU) No 1271/2013 of 30 September 2013 on the framework
financial regulation for the bodies referred to in Article 208 of Regulation (EU, Euratom) No 966/2012 of the
European Parliament and of the Council (6), and in particular Article 108 thereof,
— having regard to Rule 94 of and Annex IV to its Rules of Procedure,
— having regard to the report of the Committee on Budgetary Control and the opinion of the Committee on the
Environment, Public Health and Food Safety (A8-0135/2019),
1. Approves the closure of the accounts of the European Medicines Agency for the financial year 2017;
2. Instructs its President to forward this decision to the Executive Director of the European Medicines Agency, the
Council, the Commission and the Court of Auditors, and to arrange for its publication in the Official Journal of the
European Union (L series).
The President The Secretary-General
Antonio TAJANI Klaus WELLE
(1) OJ C 434, 30.11.2018, p. 141.
(2) OJ C 434, 30.11.2018, p. 141.
(3) OJ L 298, 26.10.2012, p. 1.
(4) OJ L 193, 30.7.2018, p. 1.
(5) OJ L 136, 30.4.2004, p. 1.
(6) OJ L 328, 7.12.2013, p. 42.